Edwin Urrutia
About Edwin Urrutia
Edwin Urrutia is an experienced analyst and co-founder, currently holding positions at Phoenixus AG and Pyros Pharmaceuticals, as well as serving as Vice President at Travere Therapeutics and Analyst at Piper Sandler.
Work at Piper Sandler
Edwin Urrutia has served as an Analyst at Piper Sandler since 2011. In this role, he has contributed to various analytical projects and provided insights that support the firm's investment strategies. His tenure at Piper Sandler spans over 13 years, during which he has gained extensive experience in financial analysis and market research.
Current Roles at Phoenixus AG and Pyros Pharmaceuticals
Edwin Urrutia co-founded Phoenixus AG in 2014 and has been involved in its operations for 10 years. Additionally, he co-founded Pyros Pharmaceuticals in 2017, where he holds the position of Chief Operating Officer. His leadership in these companies focuses on strategic development and operational management.
Position at Travere Therapeutics
Since 2013, Edwin Urrutia has held the position of Vice President at Travere Therapeutics. In this role, he is responsible for overseeing various therapeutic initiatives and contributing to the company's strategic direction. His experience in the pharmaceutical sector enhances the company's operational effectiveness.
Education and Expertise
Edwin Urrutia earned a Bachelor’s Degree in Finance from Northeastern University. His educational background provides a solid foundation for his analytical skills and expertise in financial management, which he applies in his various roles across the companies he is involved with.